These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9096233)

  • 21. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Backbone dynamics of receptor binding and antigenic regions of a Pseudomonas aeruginosa pilin monomer.
    Suh JY; Spyracopoulos L; Keizer DW; Irvin RT; Sykes BD
    Biochemistry; 2001 Apr; 40(13):3985-95. PubMed ID: 11300779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological studies of the disulfide bridge region of Pseudomonas aeruginosa PAK and PAO pilins, using anti-PAK pilus and antipeptide antibodies.
    Lee KK; Sastry PA; Paranchych W; Hodges RS
    Infect Immun; 1989 Feb; 57(2):520-6. PubMed ID: 2563257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Backbone dynamics of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pilin strain PAK from heteronuclear 1H-15N NMR spectroscopy.
    Campbell AP; Spyracopoulos L; Irvin RT; Sykes BD
    J Biomol NMR; 2000 Jul; 17(3):239-55. PubMed ID: 10959631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
    Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
    Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure at high resolution of ferric-pyochelin and its membrane receptor FptA from Pseudomonas aeruginosa.
    Cobessi D; Celia H; Pattus F
    J Mol Biol; 2005 Sep; 352(4):893-904. PubMed ID: 16139844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipid (Asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins.
    Yu L; Lee KK; Hodges RS; Paranchych W; Irvin RT
    Infect Immun; 1994 Dec; 62(12):5213-9. PubMed ID: 7525482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
    Macht M; Fiedler W; Kürzinger K; Przybylski M
    Biochemistry; 1996 Dec; 35(49):15633-9. PubMed ID: 8961925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of protein OprF of Pseudomonas in bivalent vaccines.
    Hancock RE; Wong R
    Behring Inst Mitt; 1997 Feb; (98):283-90. PubMed ID: 9382752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
    Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
    Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
    Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.